We applied both human monoclonal anti-SARS-Cov-2 antibodies (spike protein, nucleoprotein) and rabbit polyclonal anti-SARS-Cov-2 antibodies (envelope protein, membrane protein) to 55 different tissue ...

Researchers from medical research institute WEHI (Melbourne, Australia) have shown a new drug compound can prevent long COVID symptoms in mice – a  landmark finding that could lead to a future ...

Chiropractic physician Dr. Cathleen Gerenger joined Gayle Guyardo, host of the global health and wellness show Bloom, to discuss long COVID symptoms and the findings of a ...

Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 healthcare workers in Catalonia who were followed during three years. The ...

The spike protein of the coronavirus, or SARS-CoV-2, binds to ACE2, a receptor on the host cells ... “We simulated the electronic structure of the two interacting molecules and assessed how amino ...

SARS-CoV-2 is able to infect human cells by binding its spike (S) protein to angiotensin-conversing enzyme 2 (ACE2), which is expressed abundantly in several cell types and tissues. ACE2 has extensive ...

A novel antiviral targeting the SARS-CoV-2 PLpro protease shows strong efficacy in a mouse model, preventing lung pathology and reducing brain dysfunction. The study provides proof-of-principle ...

Researchers have shown a new drug compound can prevent long COVID symptoms in mice—a landmark finding that could lead to a ...

Scientists achieved “a milestone” by charting the activity and structure of 200,000 cells in a mouse brain and their 523 ...